Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Émilie Mosnier, Cyril Farnarier, Marine Mosnier

    Sante Publique (Vandoeuvre-Les-Nancy, France)
    |June 20, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cost-effectiveness of a real-time screening strategy for bacterial vaginosis using qPCR to prevent preterm birth: results from a randomized prospective multicenter study.

    Cost effectiveness and resource allocation : C/E·2026
    Same author

    First lessons from the evaluation of CoFoR, an adaptation of the recovery college model in France for mental health promotion, peer support, and recovery.

    L'Encephale·2026
    Same author

    Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign.

    Emerging microbes & infections·2026
    Same author

    Socioeconomic inequalities and the COVID-19 pandemic in France: Territorial analyzes based on epidemic wave and metropolitan area.

    PloS one·2026
    Same author

    Antibiotic resistance prediction with an attention-based bi-LSTM clinical decision support system.

    Computer methods and programs in biomedicine·2026
    Same author

    Toxoplasmosis Acquired in French Guiana in Immunocompetent Adults: Case Series From 2002 to 2019, With a Focus on Outpatients.

    Open forum infectious diseases·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    Same journal

    Sante publique (Vandoeuvre-les-Nancy, France)·2026
    See all related articles

    Mobile outreach teams provided tailored COVID-19 testing and monitoring for homeless individuals in Marseille. This approach addressed healthcare gaps and aimed to mitigate the impact of the pandemic on this vulnerable population.

    Area of Science:

    • Public Health
    • Infectious Disease Epidemiology
    • Social Determinants of Health

    Background:

    • Homeless populations face heightened COVID-19 infection risk due to challenging living conditions hindering prevention.
    • Precarious housing situations exacerbate vulnerability to infectious diseases like COVID-19.

    Purpose of the Study:

    • To implement adapted COVID-19 testing and monitoring strategies for homeless individuals in Marseille.
    • To address the specific healthcare needs of people experiencing homelessness during the pandemic.

    Main Methods:

    • Coordinated 18 support organizations for the homeless.
    • Trained personnel and provided rapid serological and antigenic tests.
    • Deployed a mobile outreach team offering point-of-care PCR testing, prevention, and case monitoring.

    Related Experiment Videos

    Main Results:

    • The intervention demonstrated good participant acceptability and field organization.
    • Mobile teams successfully provided COVID-19 testing, including PCR, and monitoring.
    • Lack of adequate accommodation was identified as a significant barrier to care.

    Conclusions:

    • COVID-19 highlighted existing healthcare access issues for homeless people.
    • Specialized mobile outreach teams are crucial for managing infectious disease impacts in this high-risk group.